Our academic collaborators’ seminal contributions push the field forward
Our constellation of renowned thinkers and partners
The right collaborators across pharma, biotech and nonprofit
The next generation of scientific leaders in cancer immunotherapy
Stories & Announcements
PICI in the News
Resources for Press
PICI Welcomes New Staff Members
PICI Members and Partners Featured at #CARTCR
Developing Next-Gen Scientific Leaders: The Parker Institute for Cancer Immunotherapy Awards up to $2.9 Million to Eight Early Career Investigators
Develop breakthrough immune therapies to turn all cancers into curable diseases faster
The driving force behind PICI’s research and operations
Join us. Change lives.
At PICI, we take on high-risk, high-reward research projects in four key areas that hold the most promise to advance immunotherapy and help patients. We empower our visionary scientists and clinicians to tackle the hardest questions in order to accelerate the next cancer breakthroughs.
Challenge: To engineer a smarter army of next-gen cell therapies that seek out specific targets and attack cancer — again and again.
Challenge: To uncover why some patients respond to checkpoint inhibitors for cancer while others don’t. If we know when and how immunotherapy resistance arises, we can prevent or even reverse it.
Challenge: To find the “red flags” that show us where cancer is hiding. By pinpointing these antigens that fire up our immune system, we can create more effective personalized anti-cancer therapies.
Challenge: To infiltrate a solid tumor’s defenses. How can we break down the tumor microenvironment that walls off cancer from immunotherapy treatments?